SEC 8-K and 6-K filings classified by Claude with reasoning, plus Form 4 insider transactions. Ingested from EDGAR’s filing stream in near-real time, reconciled overnight.
Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
ESS Tech received a written notice from NYSE on June 9, 2026, indicating failure to satisfy the continued listing standard under Section 802.01C due to average closing price below $1.00 per share. The company has a six-month cure period and may pursue remedies including a reverse stock split to regain compliance.
View raw filing on EDGAR →The filing discloses the appointment of Laura Boettcher as Chief Operating Officer of Hippo Holdings Inc., effective June 10, 2026. While the disclosure also includes compensatory details (base salary of $450,000, bonus eligibility, and equity grants), the principal action is her appointment to a C-suite officer role. The appointment of a COO is material to investors as it reflects organizational leadership changes and operational oversight structure.
View raw filing on EDGAR →Vivakor converted $103,100.78 in convertible promissory notes into 355,979 shares of common stock in an unregistered private placement under Section 4(a)(2). The underlying Lender Notes total $5.1 million in principal, representing a material dilutive issuance to existing shareholders.
View raw filing on EDGAR →Vivakor issued a press release on June 9, 2026 disclosing the Company's first quarter 2026 financial results. The earnings announcement was furnished along with operational updates and shareholder meeting notices issued on June 10 and 11, 2026.
View raw filing on EDGAR →This press release announces FDA approval of Obagi® saypha® ChIQ™, a new injectable hyaluronic acid gel product for the Obagi Medical brand (owned by Waldencast). The approval expands Obagi's injectable portfolio and strengthens its position in the dermal filler market. This is a material operational/product milestone—a regulatory approval that materially expands the company's addressable market in the fast-growing U.S. dermal filler category and advances its strategy to establish Obagi as a comprehensive leader in medical aesthetics. While not a discrete M&A, litigation, or financial event, the approval of a new product with significant market potential is material to investors assessing the company's growth trajectory and competitive positioning.
View raw filing on EDGAR →This is a clear disclosure of shareholder vote results from Nextdoor's June 9, 2026 Annual Meeting of Stockholders. The filing reports voting outcomes on three proposals: election of a Class II director (David Sze), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The detailed vote tallies and passage of all three proposals are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from Victoria's Secret & Co.'s June 11, 2026 annual meeting, covering three proposals: election of nine directors, advisory approval of named executive officer compensation, and ratification of Ernst & Young LLP as independent auditor. The detailed voting tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the hallmark of Item 5.07 shareholder vote results disclosures, which are material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →Castellum announced that its joint venture won a position on a $250 million U.S. Navy logistics IT multiple award contract. While this represents a significant business development and potential revenue opportunity, it does not fit neatly into the more specific event categories (it is not an M&A transaction, earnings release, executive change, or other defined material event type). The contract award is material to investors as a substantial government contract win, but the disclosure is best classified as other_material given the absence of a more precise taxonomy match.
View raw filing on EDGAR →This disclosure reports the Net Asset Value (NAV) per share as of May 31, 2026, for a diversified real estate income trust across multiple share classes. NAV reporting is a standard and material disclosure for REITs and closed-end funds, as it directly informs investors of the per-share value of their holdings and is used to assess performance and pricing. While this is routine periodic reporting rather than an unexpected event, it is material to investors' assessment of the registrant's financial position and does not fit neatly into the more specific event categories (e.g., it is not an earnings release with comprehensive financial results, nor a restatement, impairment, or other discrete event).
View raw filing on EDGAR →The 6-K discloses termination of an at-the-market (ATM) sales agreement with AC Sunshine Securities LLC under which the Company sold 39,248,940 Class A Ordinary Shares for gross proceeds of $30.97 million. While the primary disclosure is the termination, the material event is the dilutive equity issuance itself—a substantial unregistered offering that raised significant capital and diluted existing shareholders. The magnitude (39+ million shares, ~$31 million proceeds) and the ATM structure (characteristic of dilutive capital raises at smaller issuers) make this material to investors.
View raw filing on EDGAR →The CEO and principal shareholder voluntarily surrendered 3,000,000 shares (approximately 49% of outstanding shares) for zero consideration, reducing total outstanding shares from 6,134,780 to 3,134,780. While this is a capital structure change rather than a traditional M&A, restatement, or executive departure, it materially affects share count, ownership concentration, and EPS calculations—information a reasonable investor would consider significant. The voluntary nature and zero-consideration treatment as a capital contribution distinguish this from standard buybacks or dilutive issuances.
View raw filing on EDGAR →This Item 8.01 disclosure provides a comprehensive NAV update as of May 31, 2026, including detailed valuation methodologies, portfolio composition, and recent loan originations totaling approximately $479 million. While the filing acknowledges that "transactions or events have occurred since May 31, 2026 that could have a material impact on our NAV per share," the disclosure itself is primarily informational regarding NAV calculation and portfolio status rather than announcing a specific material event (such as impairment, covenant breach, or going concern). The NAV update and portfolio activity are material to investors in this closed-end fund, but do not fit neatly into more specific event categories.
View raw filing on EDGAR →Elliott Rodgers, a Board member, tendered his resignation effective June 15, 2026, in connection with his appointment as an executive officer at Kohl's Corporation. The principal disclosed action is a director's departure from the Board. While the filing notes the Board intends to decrease size to 11 directors, the core event is Rodgers' resignation, making this an exec_departure rather than a routine administrative matter.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from the June 10, 2026 Annual Meeting of Stockholders, including election of directors (Evelyn Dilsaver and Mark Hancock), ratification of Ernst & Young LLP as independent auditor, and advisory approval of named executive officer compensation. The filing explicitly states all three proposals were approved, which is the core content of Item 5.07.
View raw filing on EDGAR →The FDA accepted Inhibrx's Biologics License Application (BLA) for ozekibart (INBRX-109) with a PDUFA goal date of April 14, 2027, representing a material regulatory milestone in the company's clinical development program.
View raw filing on EDGAR →Ares Core Infrastructure Fund's wholly-owned subsidiaries entered into a $910 million senior secured term loan credit facility on June 9, 2026, representing a material refinancing and capital structure transaction affecting the Fund's leverage position and financial obligations.
View raw filing on EDGAR →The Fund terminated its Initial Rover Credit Agreement (approximately $1.09 billion outstanding) and repaid all loans, replacing it with a new Rover Credit Agreement—a material refinancing transaction affecting the registrant's capital structure and debt obligations.
View raw filing on EDGAR →The Rover Borrower (a portfolio company of the Fund) entered into an interest rate swap with Morgan Stanley Bank on June 9, 2026, covering 50% of outstanding borrowings under the Rover Term Loan at a fixed rate of 4.085% through June 2033, materially affecting the Fund's interest rate exposure and debt service obligations.
View raw filing on EDGAR →The filing discloses a distribution payment of $0.19 per share (gross) across five classes of common stock on June 12, 2026, with net distributions ranging from $0.1770 to $0.1900 after servicing fees. While distribution announcements are routine for REITs and closed-end funds, this disclosure does not fit cleanly into the standard taxonomy categories (it is not an earnings release, which would typically include full financial results). The materiality to shareholders is evident—distributions directly affect investor returns—but the event itself is a routine capital allocation action rather than a material corporate event that signals financial stress, opportunity, or governance change.
View raw filing on EDGAR →Franklin BSP Real Estate Debt, Inc. entered into Amendment No. 2 to an Uncommitted Master Repurchase Agreement with JPMorgan Chase Bank and executed an Amended and Restated Guarantee Agreement whereby the Company assumes guarantor obligations for its subsidiary's repurchase facility. The amendment modifies the agreement's Change of Control provisions and replaces the guarantor, creating material modifications to the Company's direct financial obligations.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from the Company's 2026 annual meeting held on June 15, 2026. The filing reports final voting tallies for two proposals: election of six directors (all elected with substantial majorities) and ratification of Deloitte & Touche LLP as independent auditor (ratified with overwhelming support). Director elections and auditor ratification are material governance matters affecting investor confidence in board composition and financial oversight.
View raw filing on EDGAR →Target held its 2026 Annual Meeting of Shareholders on June 10, 2026, with voting results on seven proposals including director elections, auditor ratification, executive compensation approval, and long-term incentive plan amendments. The filing discloses detailed voting tallies for each proposal.
View raw filing on EDGAR →The filing discloses a material acquisition in progress: IBCP's proposed acquisition of HCB Financial Corp., with a definitive merger agreement signed March 18, 2026. The June 12, 2026 disclosure announces regulatory approvals from the Federal Reserve Bank of Chicago and Michigan Department of Insurance and Financial Services, representing a significant milestone toward completion. This is a classic M&A activity disclosure under Item 8.01, material to investors assessing the registrant's strategic direction and future financial profile.
View raw filing on EDGAR →The disclosure centers on compensatory arrangements for Swen Neufeldt, a Group Vice President, including modifications to his base salary structure (addition of $56,103 cost-of-living adjustment), relocation payments ($20,000), housing allowance ($90,566 annually), and various other benefits totaling substantial additional compensation tied to his international assignment. While the assignment itself is administrative, the material substance of the 8-K Item 5.02 filing is the new compensatory package and benefits arrangement.
View raw filing on EDGAR →This disclosure reports a jury verdict in a wrongful termination and whistleblower protection lawsuit against Ameris Bank, with a total judgment of approximately $79.4 million ($16.525 million in economic/non-economic damages plus $62.9 million in punitive damages). The Company explicitly states the verdict "could have a material adverse effect on the Company's results of operations, financial condition and liquidity," and is evaluating whether an accrual is required for financial reporting purposes, indicating materiality to investors.
View raw filing on EDGAR →The disclosure centers on Kristen Johnson's separation from H2O America, effective July 3, 2026, following a mutual agreement on June 10, 2026. The Company classified the separation as "without cause" and committed to severance payments under her employment agreement. This is a clear executive departure event, material to investors as it affects the composition of management and involves severance obligations.
View raw filing on EDGAR →Santander Holdings USA disclosed its Q2 2026 financial results on June 12, 2026, including results of operations and financial condition for the period.
View raw filing on EDGAR →The filing discloses the election of Vishal Talwar as a director of Fastenal Company effective June 12, 2026, increasing the Board from eleven to twelve members. Mr. Talwar, currently Executive Vice President and Chief Digital and Information Officer at FedEx Corporation, was also appointed to the Nominating and Corporate Governance Committee. This is a clear director appointment that would be material to investors assessing Board composition and governance.
View raw filing on EDGAR →Val Bauduin was designated as Starbucks' principal accounting officer on June 11, 2026, with principal accounting officer responsibility transferring from CFO Cathy Smith to Bauduin. While Bauduin retains his existing SVP title and compensation, the designation of a principal accounting officer is a material executive appointment affecting the company's financial reporting structure and governance. The disclosure emphasizes his background as controller and chief accounting officer at Marriott, underscoring the significance of this accounting leadership role.
View raw filing on EDGAR →Isabella Bank Corporation entered into an Agreement and Plan of Merger with Grand River Commerce, Inc. on June 11, 2026, with a joint press release issued on June 12, 2026. This constitutes entry into a material acquisition/merger transaction, which is a core M&A activity event requiring disclosure under Item 1.01 or related provisions. The disclosure of the executed Merger Agreement and supplemental investor presentation clearly signals a material change of control or acquisition event.
View raw filing on EDGAR →The Board approved the Annual Incentive Bonus Plan for fiscal 2027 on June 11, 2026, establishing compensatory arrangements for executive officers including target award opportunities (165% of base salary for CEO, 115% for CFO, 100-110% for other NEOs) and performance metrics tied to operating profit, free cash flow, and revenue. This is a classic Item 5.02(e) disclosure of executive compensation plan terms and is material to investors assessing executive incentive structures.
View raw filing on EDGAR →This disclosure describes entry into material definitive agreements (Third Modification Agreement, Amended and Restated Installment Note, and Second Installment Note) that substantially modify an existing senior secured construction loan. The amendments increase the principal commitment by approximately $9.9 million to a total of $36.0 million, extend maturity to August 2027, and document revised interest rate terms. While technically a loan modification rather than a traditional M&A transaction, the Item 1.01 classification and the material nature of the financing arrangement (significant capital commitment for a major development project) warrant classification as a material financing activity that would affect investor assessment of the registrant's capital structure and project funding.
View raw filing on EDGAR →Freedom Holding Corp. is launching an offering of common stock for up to US$300 million pursuant to Regulation S, with bookbuilding commencing in mid-June 2026 at US$126.35 per share. This is a material dilutive equity issuance that would affect a reasonable investor's assessment of share dilution and capital structure, even though it is being conducted offshore under Regulation S rather than as a registered domestic offering.
View raw filing on EDGAR →McKesson entered into an amendment to its Credit Agreement on June 9, 2026, adding a $2.25 billion senior secured Term B Loan Facility due 2032. This material financing arrangement affects the company's capital structure and leverage profile but does not constitute a traditional M&A transaction.
View raw filing on EDGAR →Descartes Systems Group held its annual meeting of shareholders on June 11, 2026, with voting results disclosing the election of all 9 director nominees, appointment of KPMG LLP as auditors, approval of shareholder rights plan amendments, and approval of the say-on-pay resolution.
View raw filing on EDGAR →The Compensation Committee approved a form of Restricted Stock Unit Award Agreement under the 2026 Incentive Plan on June 10, 2026. This is a compensatory arrangement for officers and directors involving equity grants, which falls squarely within the exec_compensation category. The approval of a plan form document that will govern future RSU awards is material to investors assessing executive compensation practices.
View raw filing on EDGAR →The 6-K discloses a credit rating upgrade by S&P Global Ratings from "B-" to "B" for Transportadora de Gas del Sur's long-term local and foreign currency debt, effective June 11, 2026, following a revision of Argentina's transfer and convertibility risk assessment. This is a material financial event affecting the company's cost of capital and creditworthiness, but does not fit a specific named event type (not debt issuance, covenant breach, or impairment); it is classified as financial_other.
View raw filing on EDGAR →The filing discloses a scheduled payment notice for IRSA's Fixed Rate Series XIV Notes due 2028, specifying that on June 22, 2026, the company will pay the eighth installment of interest (USD 2,937,373.73) and the third installment of capital (USD 18,076,146.03). While this is a debt service payment rather than a traditional dividend, it represents a material distribution of capital and interest to security holders on a specified date and is customarily disclosed as a dividend_distribution event in the context of debt instruments.
View raw filing on EDGAR →FB Bancorp announced authorization of a share repurchase program for approximately 10% of outstanding shares (1,606,837 shares). While share repurchases are material capital allocation decisions affecting shareholder value and EPS, they do not fit neatly into the more specific event categories (not an earnings release, executive change, M&A, impairment, or other defined event type). This is classified as other_material because it represents a significant corporate action that would affect a reasonable investor's assessment of the company's capital strategy and financial position.
View raw filing on EDGAR →The filing discloses the appointment of David A. Holmes as President and Chief Executive Officer effective June 12, 2026, following the removal of Kevin Mills from that role on June 8, 2026. While both a departure and appointment occur, the principal disclosed action centers on the appointment of the new CEO with detailed biographical information and compensation terms. This is a material executive change affecting the registrant's leadership.
View raw filing on EDGAR →The disclosure centers on material M&A activity: Cintas's pending acquisition of UniFirst under a Merger Agreement dated March 10, 2026. The filing reports that UniFirst shareholders voted to approve the acquisition on June 12, 2026, and that the FTC issued a Second Request on June 11, 2026, extending the HSR Act waiting period. The transaction is expected to close in the second half of 2026 subject to regulatory approvals and customary closing conditions. This is a major acquisition material to investors.
View raw filing on EDGAR →Sleep Number Corporation and its subsidiaries filed voluntary petitions for relief under Chapter 11 of the Bankruptcy Code on June 12, 2026, in the U.S. Bankruptcy Court for the Southern District of New York. The filing triggered automatic acceleration of approximately $672.5 million in debt and includes debtor-in-possession financing and a stalking horse asset sale agreement.
View raw filing on EDGAR →This disclosure announces early tender results for debt tender offers and consent solicitations by QXO's subsidiary in connection with QXO's pending acquisition of TopBuild Corp. The filing reports that 99.54% of the 2032 Notes and 99.72% of the 2034 Notes were tendered, and that requisite consents were obtained to execute supplemental indentures eliminating change-of-control offers and restrictive covenants. This is a material component of the TopBuild Acquisition transaction structure, directly facilitating the M&A activity.
View raw filing on EDGAR →Avis Budget issued $650 million in asset-backed securities through its ABRCF subsidiary on June 9, 2026, comprising multiple series and classes of notes secured by domestic fleet vehicles. This material capital structure transaction involved entry into definitive agreements (Series 2026-3 and 2026-4 Supplements to the Base Indenture) that affect the company's financial position and leverage.
View raw filing on EDGAR →DHT Holdings announced entry into an agreement with Hanwha Ocean for construction of a new VLCC vessel scheduled for delivery in August 2028, representing a material capital deployment and fleet expansion decision financed through cash flow, liquidity, and projected mortgage debt.
View raw filing on EDGAR →DHT Holdings entered into a new $250 million reducing revolving credit facility with a seven-year tenor, SOFR plus 135 basis points margin, and final maturity in June 2033, enhancing the company's financial flexibility and extending its debt maturity profile.
View raw filing on EDGAR →This is a classic Item 5.07 disclosure of shareholder vote results from the June 10, 2026 annual meeting. The filing reports final voting tallies certified by the independent inspector of election for three proposals: election of two Class III directors (David M. Tolley and Stephen H. Deckoff), advisory approval of named executive officer compensation, and ratification of Grant Thornton LLP as independent auditor. The detailed vote counts for each proposal are the core content of the disclosure.
View raw filing on EDGAR →BioRestorative Therapies entered into a $1,000,000 Revolving Loan Agreement with Bowery Group LLC on June 10, 2026, which includes lender rights to designate directors, representing a material change of control indicator and significant shift in governance and financial control.
View raw filing on EDGAR →This is a clear disclosure of shareholder voting results from W. P. Carey's annual meeting held on June 11, 2026, covering four proposals: election of nine directors, advisory vote on named executive officer compensation, advisory vote on compensation frequency, and ratification of PricewaterhouseCoopers LLP as independent auditor. The filing presents final vote tallies for each proposal, which is the quintessential content of Item 5.07 shareholder vote results disclosures and is material to investors assessing board composition and governance.
View raw filing on EDGAR →The 6-K discloses a scheduled capital payment on Series XL Fixed Rate Notes (USD 38.2 million principal, issued December 21, 2022). The filing announces the second installment of capital repayment scheduled for June 22, 2026, with USD 12.6 million being paid. While this is a debt service event on existing obligations rather than issuance of new debt, it represents a material financial obligation and cash outflow that would affect investor assessment of the registrant's liquidity and capital structure. The debt itself was created in 2022; this disclosure documents the scheduled amortization schedule.
View raw filing on EDGAR →